TLR4 and metabolic dysfunction-associated steatotic liver disease: Animal studies have shown that some bacterial strains, such as Lactobacillus, have the ability to reduce the inflammation caused by high levels of lipopolysaccharide (LPS) and subsequent hepatic toll-like receptor 4 (TLR4) activation in NAFLD patients (35).